Humacyte Advances with $15M Direct Offering
Humacyte ( (HUMA) ) has provided an announcement. Humacyte, Inc. has announced a $15 million registered direct offering, selling common stock ...
Humacyte Announces Pricing of $15.0 Million Registered Direct Offering
DURHAM, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, ...
World Diabetes Day: Advances in vascular surgery provide new hope for diabetic foot complications
Minimally invasive techniques require only small incisions, reducing the likelihood of complications and promoting a quicker ...
Humacyte Third Quarter 2024 Financial Results and Business Update
DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Organogenesis (ORGO) Set to Announce Quarterly Earnings on Tuesday
Organogenesis (NASDAQ:ORGO – Get Free Report) will release its earnings data after the market closes on Tuesday, November ...